Rankings
▼
Calendar
PBYI Q1 2017 Earnings — Puma Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena
PBYI
Puma Biotechnology, Inc.
$299M
Q1 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$73M
Net Income
-$73M
EPS (Diluted)
$-1.97
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$36M
Free Cash Flow
-$36M
Stock-Based Comp.
$30M
Balance Sheet
Total Assets
$217M
Total Liabilities
$49M
Stockholders' Equity
$167M
Cash & Equivalents
$105M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$73M
-$71M
-2.7%
Net Income
-$73M
-$71M
-2.7%
← FY 2017
All Quarters
Q2 2017 →